Bio Break: Clinical Trials for Medical Devices vs. Pharmaceuticals

Resources

Bio Break: Clinical Trials for Medical Devices vs. Pharmaceuticals

Topic: Bio Break

In this episode of Bio Break, Joris van der Heijden and Nick Allan break down the key differences and similarities between clinical trials for medical devices and pharmaceutical products. As the conversation unfolds, they provide valuable insights into the distinct processes and challenges associated with these two types of trials, including the complexities of combination devices that bridge both worlds.

Nick begins by explaining the unique goals of clinical trials for medical devices. These trials focus on proving safety, efficacy, and the performance claims of the device in real-world settings. For example, diagnostic devices must demonstrate their ability to detect targets reliably and accurately, whether in a clinical laboratory or at the point of care.

In contrast, Nick outlines the four distinct phases of pharmaceutical clinical trials:

  • Phase 1: Conducted with healthy volunteers to evaluate safety and dosage, often involving a small group of participants (around 50 people).
  • Phase 2: Tests the drug’s efficacy in the target patient population, expanding the study to hundreds of participants.
  • Phase 3: Compares the drug against existing treatments or the standard of care in a much larger population, often with thousands of participants, to prove differentiation and effectiveness.
  • Phase 4: Post-market surveillance monitors long-term safety, side effects, and real-world performance after regulatory approval.

Nick highlights how medical device trials share parallels with pharmaceutical trials but often focus on different priorities, such as functional testing, usability, and regulatory claims. The discussion becomes especially intriguing when considering combination products, which integrate medical devices with pharmaceutical components, requiring alignment across both regulatory pathways and clinical trial objectives.

This episode is essential viewing for anyone working in medical device development, pharmaceuticals, or combination products. Gain a clear understanding of the clinical trial landscape and how these processes ensure safety, efficacy, and market readiness for innovative healthcare solutions.

Clinical Trials for Medical Devices vs. Pharmaceuticals

YouTube video thumbnail
A red defibrillator inside a white wall-mounted cabinet labeled DEFIBRILLATOR. A red arrow points to it, with overlay text reading ‘Locked away?’ in bold black letters on a white highlight.

Even the best-designed devices, prepared with careful simulations and usability studies, can behave very differently when used in actual clinical or emergency situations.

A hand holds a blue asthma inhaler against a light blue background. A red arrow points to the inhaler. Overlay text reads: ‘Used Wrong?’ in bold black letters on a white highlight.

Nigel Syrotuck and Nick Allan explore the surprising reality of inhaler spacer use. While these devices are often thought of as tools for children with asthma, research shows that adults struggle with them too.

Futuristic laboratory with multiple glowing blue cylindrical tanks emitting mist. A red arrow points to one tank. Overlay text reads: ‘Bacta tank. For real?’ in bold white letters on a black background.

Ariana Wilson and Mark Drlik take inspiration from a scene in The Empire Strikes Back to talk about real-world parallels to the Star Wars bacta tank.

A medical professional wearing a white coat and blue gloves holds a red cooler labeled ‘Organ Transport.’ Overlay text reads: ‘The call came’ in bold black letters on a white highlight.

In this Before the Build episode, Eric Olson and Paul Charlebois dive into the importance of organ transplant logistics when designing effective medical devices.